Therefore, we determined the role of ERK-mediated ferroptosis in the emergence of gefitinib resistance in HNSCC cells and suggested that EMP1 could sensitize HNSCC cells to gefitinib by ferroptosis induction via blocking p-ERK activation. This evidence concerns the gene EMP1 and head and neck squamous cell carcinoma.